Summary
- Current Price
- As of today, SABS price is $3.17, down -1.55% on
- Current Price All-Time High
- SABS price is currently -97.54% below its historical high of $129.00 set on
- Market Cap
- SABS current market cap is $288M, up +202.13% over the past 365 days
- Revenue
- SABS current annual revenue is $0.00, down -100.00% year-over-year
- Next Earnings
- The next earnings release for SABS is on
Profile
| Metric | Value |
|---|---|
| Full Name | SAB Biotherapeutics, Inc. |
| Ticker | NASDAQ: SABS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | sabbiotherapeutics.com |
| Employees | 63 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $3.17 | ||
| Price, 1D Change | -1.55% | |
| $288M | ||
| - | ||
| - | ||
| 1.27 | ||
| $0.00 | ||
| Revenue, 1Y Change | -100.00% | |
| -$0.79 | ||
| EPS, 1Y Change | +78.43% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | BCYP | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.79 | ||
| EPS Estimate | -$1.16 | N/A |
| EPS Est. Change | -46.35% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| $3.17 | ||
| Price Target | $12.00 | - |
| Price Tgt. Change | +278.55% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.64 | -$3.68 | -1.16% | |
| -$1.00 | -$0.79 | +20.56% | |
| -$1.16 | N/A | -46.35% | |
| -$0.95 | N/A | -20.12% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.32M | $1.32M | -0.06% | |
| - | $0.00 | - | |
| - | N/A | - | |
| $62.50K | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| +57.71% | ||
| -49.68% | ||
| +202.13% | ||
| +775.06% | ||
| -100.00% | ||
| -100.00% | ||
| +78.43% | ||
| +81.55% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $3.17 | ||
| $3.78 | ||
| $3.61 | ||
| $3.57 | ||
| $3.56 | ||
| -$0.12 | ||
| 1.27 | ||
| $0.16 | ||
| 32.03 | ||
| 37.69% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$0.79 | ||
| -$3.08M | ||
| - | ||
| -$48.95M | ||
| - | ||
| $4.26M | ||
| - | ||
| -$45.87M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.04 | ||
| 9.46 | ||
| 9.46 | ||
| - | ||
| - | ||
| 6.32 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 1.34 | ||
| -2.78 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $151.49M | ||
| $96.59M | ||
| $174.52M | ||
| $101.05M | ||
| $23.02M | ||
| $10.68M | ||
| $5.95M | ||
| $951.40K | ||
| $3.15M |
Expenses
| Metric | Value | Date |
|---|---|---|
| -$4.26M | ||
| $45.87M | ||
| $3.08M | ||
| $0.00 | ||
| $3.08M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$44.78M | ||
| -$121.71M | ||
| $168.30M | ||
| $933.20K | ||
| -$45.71M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Barclays | ||
| Chardan Capital | → | |
| Leerink Partners | → | |
| HC Wainwright & Co. | → | |
| Citigroup | ||
| Jefferies | ||
| HC Wainwright & Co. | → | |
| Rodman & Renshaw | → | |
| Rodman & Renshaw | ||
| Chardan Capital | → |
Analyst sentiment
Institutional ownership
Screeners with SABS
FAQ
- What is the ticker symbol for SAB Biotherapeutics, Inc.?
- The ticker symbol for SAB Biotherapeutics, Inc. is NASDAQ:SABS
- Does SAB Biotherapeutics, Inc. pay dividends?
- No, SAB Biotherapeutics, Inc. does not pay dividends
- What sector is SAB Biotherapeutics, Inc. in?
- SAB Biotherapeutics, Inc. is in the Healthcare sector
- What industry is SAB Biotherapeutics, Inc. in?
- SAB Biotherapeutics, Inc. is in the Biotechnology industry
- What country is SAB Biotherapeutics, Inc. based in?
- SAB Biotherapeutics, Inc. is headquartered in United States
- When did SAB Biotherapeutics, Inc. go public?
- SAB Biotherapeutics, Inc. initial public offering (IPO) was on February 9, 2021
- Is SAB Biotherapeutics, Inc. in the S&P 500?
- No, SAB Biotherapeutics, Inc. is not included in the S&P 500 index
- Is SAB Biotherapeutics, Inc. in the NASDAQ 100?
- No, SAB Biotherapeutics, Inc. is not included in the NASDAQ 100 index
- Is SAB Biotherapeutics, Inc. in the Dow Jones?
- No, SAB Biotherapeutics, Inc. is not included in the Dow Jones index
- When was SAB Biotherapeutics, Inc. last earnings report?
- SAB Biotherapeutics, Inc.'s most recent earnings report was on August 6, 2026
- When does SAB Biotherapeutics, Inc. report earnings?
- The next expected earnings date for SAB Biotherapeutics, Inc. is November 12, 2026
Data Sources & References
- SABS Official Website www.sabbiotherapeutics.com
- SABS Profile on Yahoo Finance finance.yahoo.com/quote/SABS
- SABS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/sabs